Euro-Diagnostica AB-医療機器分野:企業M&A・提携分析

◆英語タイトル:Euro-Diagnostica AB - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012948
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Euro-Diagnostica AB (Euro Diagnostica) is a medical device company that manufactures and markets purified reagents and antibodies. The company offers blood based solutions, developed to aid clinicians in diagnosis, prognosis, monitoring and treatment of autoimmune diseases. It offers products such as alpha-MSH euria, chromogranin A euria, complement system alternative pathway WIESLAB, complement system classical pathway, complement system MBL pathway and therapy areas are rheumatoid arthritis, goodpasture’s syndrome, complement deficiency, connective tissue disorders, congenital heart block, inflammatory bowel disease and autoimmune gastroenterology, among others. The company offers custom manufacturing and lab services. It has its operations in the UK, China, Singapore, Switzerland, Germany and the Netherlands. Euro Diagnostica is headquartered in Malmo, Sweden.

Euro-Diagnostica AB – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Euro-Diagnostica AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Euro-Diagnostica AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Euro-Diagnostica AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Euro-Diagnostica AB, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Euro-Diagnostica AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Euro-Diagnostica AB, Medical Equipment, Deal Details 10
Partnerships 10
Gyros Protein Technologies Enters into Distribution Agreement with Euro Diagnostica 10
Euro-Diagnostica Enters Into Distribution Agreement With Eurospital 11
Euro Diagnostica Enters Into Distribution Agreement With Alpco Diagnostics For Assay Portfolio 12
Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel 13
Merger 14
Biomonitor Merges with Euro-Diagnostica 14
Acquisition 15
Euro-Diagnostica Acquires Vita Diagnostika 15
Euro-Diagnostica AB – Key Competitors 16
Euro-Diagnostica AB – Key Employees 17
Euro-Diagnostica AB – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Product News 19
Mar 20, 2017: New iLite FGF21 Responsive Reporter Gene Cell Line With Improved Sensitivity 19
Dec 06, 2016: Euro Diagnostica announces launch of a new Product Line – iLite Assay Ready Cells for determination of ADCC activity 20
Apr 22, 2016: Euro Diagnostica to present new data at the PEGS Summit in Boston 21
Apr 12, 2016: Euro Diagnostica announces launch of two new products – iLite Assay Ready Cells for Insulin and FGF21 22
Mar 30, 2016: New research on the use of an cell-based reporter gene iLite assay to be presented at the 10th International Congress on Autoimmunity 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Euro-Diagnostica AB, Medical Equipment, Key Facts 2
Euro-Diagnostica AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Euro-Diagnostica AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Euro-Diagnostica AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Euro-Diagnostica AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Euro-Diagnostica AB, Deals By Market, 2011 to YTD 2017 8
Euro-Diagnostica AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Gyros Protein Technologies Enters into Distribution Agreement with Euro Diagnostica 10
Euro-Diagnostica Enters Into Distribution Agreement With Eurospital 11
Euro Diagnostica Enters Into Distribution Agreement With Alpco Diagnostics For Assay Portfolio 12
Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel 13
Biomonitor Merges with Euro-Diagnostica 14
Euro-Diagnostica Acquires Vita Diagnostika 15
Euro-Diagnostica AB, Key Competitors 16
Euro-Diagnostica AB, Key Employees 17
Euro-Diagnostica AB, Other Locations 18
Euro-Diagnostica AB, Subsidiaries 18

★海外企業調査レポート[Euro-Diagnostica AB-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PEP-Therapy SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary PEP-Therapy SAS (PEP-Therapy) is a medical biotechnology company that develops targeted therapies for the treatment of cancer. The company develops cell penetrating and interfering peptides for the intracellular delivery of targeted therapies. Its pipeline products include PEP-010. PEP-Thera …
  • Tribal Group Plc (TRB):企業の財務・戦略的SWOT分析
    Tribal Group Plc (TRB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Fresenius Medical Care AG & Co. KGaA:企業の戦略・SWOT・財務情報
    Fresenius Medical Care AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary Fresenius Medical Care AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • curasan AG (CUR):医療機器:M&Aディール及び事業提携情報
    Summary curasan AG (curasan) develops, manufactures and commercializes medical devices in the field of regenerative medicine. The company offers a wide range of synthetic bone substitutes, dental and bone regeneration material products. It offers these products to orthopedic and spinal surgeons, ora …
  • Casio Computer Co Ltd (6952):企業の財務・戦略的SWOT分析
    Casio Computer Co Ltd (6952) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Royal DSM NV (DSM):医療機器:M&Aディール及び事業提携情報
    Summary Royal DSM NV (DSM) is a science-based company with focus on materials, health and nutrition. It produces vitamins, carotenoids, nutritional lipids and other ingredients; specialty plastics; and fiber and resins solutions. DSM develops materials for medical devices and clean energy from crop …
  • New Zealand Oil & Gas Ltd (NZO):企業の財務・戦略的SWOT分析
    Summary New Zealand Oil & Gas Ltd (NZOG) is an oil and gas that offers oil and gas exploration, development and production. The company acquires, explores, and develops crude oil and natural gas properties. Its producing assets include Maari and Manaia fields, Kupe gas and light oil field, and Sampa …
  • Enel SpA (ENEL)-石油・ガス分野:企業M&A・提携分析
    Summary Enel S.p.A. (Enel) is an energy group that produces, distributes and trades electricity and natural gas. The group generates electricity using diverse sources of energy such as nuclear, renewables, oil and gas turbine, coal and gas combined cycle. It also focuses on digitizing electricity gr …
  • Codexis Inc (CDXS)-製薬・医療分野:企業M&A・提携分析
    Summary Codexis Inc (Codexis) is a biotechnology company, which focuses on the development of biocatalysts for commercial scale production of fine chemicals and pharmaceuticals. The company’s product portfolio includes pharmaceutical enzymes and intermediates, active pharmaceutical ingredients (APIs …
  • United Food Holdings Limited
    United Food Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary United Food Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Unum Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Unum Therapeutics Inc (Unum) is a cancer cell therapy company that discovers, develops, and commercializes novel antibody-coupled cellular immunotherapies. The company uses its proprietary Antibody-Coupled T-cell Receptor (ACTR) technology for discovering and developing new cellular immunoth …
  • Borealis AG:企業の戦略的SWOT分析
    Borealis AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • CK Hutchison Holdings Ltd:企業の戦略・SWOT・財務情報
    CK Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary CK Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Oriental Cuisines Private Limited:企業の戦略・SWOT・財務分析
    Oriental Cuisines Private Limited - Strategy, SWOT and Corporate Finance Report Summary Oriental Cuisines Private Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Opiant Pharmaceuticals Inc (OPNT):企業の財務・戦略的SWOT分析
    Opiant Pharmaceuticals Inc (OPNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Enbridge Inc.:戦略・SWOT・企業財務分析
    Enbridge Inc. - Strategy, SWOT and Corporate Finance Report Summary Enbridge Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Impellam Group plc (IPEL):企業の財務・戦略的SWOT分析
    Impellam Group plc (IPEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • University of Leeds:医療機器:M&Aディール及び事業提携情報
    Summary University of Leeds (University of Leeds) is an educational university that offers academic programs. The university offers undergraduate, post graduate, research degrees, online and distance learning educational programs. It offers education programs in the areas of arts, biological science …
  • Charcot-Marie-Tooth Association:製薬・医療:M&Aディール及び事業提携情報
    Summary Charcot-Marie-Tooth Association (CMTA) is a healthcare service provider that offers healthcare services to patients suffering from charcot marie tooth disease. The association provides services such as public education, patient support, and research promotion. It offers services such as orth …
  • BT Group plc:戦略・SWOT・企業財務分析
    BT Group plc - Strategy, SWOT and Corporate Finance Report Summary BT Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆